Article
Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody.
Biochemical and biophysical research communications - 19 Nov 2024
Singh Vishakha, Bhutkar Mandar, Choudhary Shweta, Nehul Sanketkumar, Kumar Rajesh, Singla Jitin, Kumar Pravindra, Tomar Shailly
Abstract excerpt
The optimization of antibodies to attain the desired levels of affinity and specificity holds great promise for the development of next generation therapeutics. This study delves into the refinement and engineering of complementarity-determining regions (CDRs) through in silico affinity maturation followed by binding validation using isothermal titration calorimetry (ITC) and pseudovirus-based neutralization...
Topics
- Single-Domain Antibodies
- SARS-CoV-2
- Humans
- Antibodies, Neutralizing
- Spike Glycoprotein, Coronavirus
- Mutation
- Complementarity Determining Regions
- Molecular Dynamics Simulation
- Molecular Docking Simulation
